WebJul 1, 2024 · The activity of integrin-linked kinase (ILK) in cancerous cells is often oncogenic and associated with malignant properties, such as uncontrolled cell cycle progression and evasion from senescence.... WebDec 30, 2024 · We found that FAK inhibition suppressed the growth of gastric cancer cells, reduced xenograft tumor growth in a nude mouse model, and enhanced the therapeutic efficacy of 5-FU in the mouse model.
National Center for Biotechnology Information
WebNPTX1 promotes metastasis via integrin/FAK signaling in gastric cancer Hongfei Yan,1,2,* Chunlei Zheng,1,2,* Zhi Li,1,2 Bowen Bao,1,2 Bowen Yang,1,2 Kezuo Hou,1,2 Xiujuan Qu,1,2 Jiawen Xiao,3 Xiaofang Che,1,2 Yunpeng Liu1,2 1Department of Medical Oncology, The First Hospital of China Medical University, Shenyang 110001, China; 2Key … WebMar 1, 2024 · Zang et al. found that LPPR4 (which plays a role in promoting peritoneal metastasis of gastric cancer through Sp1/integrin α/FAK signaling) could be a new therapeutic target [102]. The binding of ... thyroid disease treatment orem ut
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer
WebMay 2, 2024 · Dickkopf-1 (DKK1) is a Wnt/ß-catenin pathway antagonist related to gastric cancer (GC) carcinogenesis. However, the prognostic role of combined DKK1 and ß-catenin expression in advanced GC (AGC) is not clear. In total, 158 patients with AGC who underwent gastric resection were enrolled in this study. DKK1 and ß-catenin expression … WebApr 2, 2024 · Five enzymes, MMP-3 and MMP-1 of MMPs system, u-PAR and u-PA of PA system, and FAK, were found to be highly expressed in poorly differentiated liver cancer cells but downregulated in small interfering RNA-PKCα (siPKCα)-treated cells (Wu et al., 2008). Further investigation into the expressions of these enzymes revealed that only the ... WebFeb 5, 2024 · Diffuse gastric cancer (DGC) is a lethal malignancy lacking effective systemic therapy. Among the most provocative recent results in DGC has been that of highly … thyroid disease treatment drugs